Biological E (BE) has partnered with Bavarian Nordic to produce the Chikungunya vaccine, VIMKUNYA CHIKV VLP, for low and ...

Hyderabad: Biological E. Limited has announced a strategic partnership with Bavarian Nordic A/S to expand access to Bavarian ...

Hyderabad: Biopharma player Biological E (BE) entered into a strategic partnership with Danish vaccine maker Bavarian Nordic ...

Biological E partners with Bavarian Nordic to expand access to Chikungunya Vaccine in low- and middle-income countries.

This partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya ...

D. Boral Capital reaffirmed their buy rating on shares of ImmunityBio (NASDAQ:IBRX – Free Report) in a research report released on Friday,Benzinga reports. The firm currently has a $30.00 target price ...

First chikungunya vaccine approved in Europe for persons as young as 12 years old. On track for launch in key European ...

The World Health Organization (WHO) today announced the recommendations for the viral composition of influenza vaccines for ...

Previous bird flu outbreaks and decades-old public health infrastructure have led industry to protect the hens used for ...

Integrating best practices in AI, genomics, cell culture, and laboratory techniques together contribute to protein expression success.

Contract manufacturing agreement marks the first step in collaboration to establish supply for expanded access to chikungunya ...